Defending American Jobs and Investment Act This bill provides for the enforcement of remedies against foreign countries that have extraterritorial or discriminatory taxes. Specifically, the bill requires the Department of the Treasury to periodically submit a report to Congress that lists each foreign country that has one or more extraterritorial or discriminatory taxes. Treasury must commence enhanced bilateral engagement with each foreign country included in the report. This engagement must (1) express the concern of the United States with respect to the adverse trade and economic effects of tax policies that violate bilateral tax treaties and international tax norms, (2) urge the repeal of extraterritorial and discriminatory taxes that target U.S. persons, and (3) advise the foreign country of remedial actions (as outlined by this bill). The bill increases income tax and withholding tax rates on certain foreign citizens, corporations, and partnerships of any foreign country listed in Treasury's report. The bill provides the executive branch with additional tools to enforce against extraterritorial and discriminatory taxes. These tools include authorizing the President to prohibit government contracting for or procurement of goods or services from a foreign country listed in Treasury's report, directing Treasury to consider these taxes in assessing whether to enter into or update a bilateral tax treaty with the foreign country, and requiring the Office of the U.S. Trade Representative and the Department of Commerce to consider these taxes in assessing whether to enter into any free trade agreement or executive agreement with the foreign country.
Referred to the Committee on Ways and Means, and in addition to the Committee on Oversight and Government Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Bill introduced
Lobbying filed by BUSINESS ROUNDTABLE INC
Lobbying filed by AMERICAN CHEMISTRY COUNCIL
Lobbying filed by LYONDELL CHEMICAL COMPANY
Lobbying filed by TOYOTA MOTOR NORTH AMERICA INC (TMA)
Referred to the Committee on Ways and Means, and in addition to the Committee on Oversight and Government Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
| Registrant | Client | Amount | Filed | Period | Issues |
|---|---|---|---|---|---|
| THE BUSINESS ROUNDTABLE, INC. | BUSINESS ROUNDTABLE INC | $6.9M | Apr 21, 2025 | 2025Q1 | ENGENVFIN |
| AMERICAN CHEMISTRY COUNCIL | AMERICAN CHEMISTRY COUNCIL | $4.2M | Apr 21, 2025 | 2025Q1 | CAWCHMTAX |
| TOYOTA MOTOR NORTH AMERICA, INC. (TMA) |
The lobbying table lists Senate LDA quarterly reports (LD-2) that cite this bill by number and cover a quarter of the 119th Congress. An LD-2 names a bill as “H.R. 1234” with no Congress, so a report on another Congress, which can only concern a different bill with the same number, is left out, even when it was filed after this Congress began. The amount is what the registrant reported for the whole filing, across every issue on it, not spending on this bill. Official actions and the bill summary come from Congress.gov, and votes from the roll-call record. This page no longer pairs the bill with members' stock trades: matching lobbying clients to traded companies by name, and trades to a bill by date, is not something the records establish.
Lobbying filed by ASTRAZENECA PHARMACEUTICALS LP
| TOYOTA MOTOR NORTH AMERICA INC (TMA) |
| $1.9M |
| Jul 17, 2025 |
| 2025Q2 |
CSPSCITRD |
| ASTRAZENECA PHARMACEUTICALS LP | ASTRAZENECA PHARMACEUTICALS LP | $1.8M | Jul 21, 2025 | 2025Q2 | HCRMMMPHA |
| LYONDELL CHEMICAL COMPANY | LYONDELL CHEMICAL COMPANY | $1.7M | Apr 21, 2025 | 2025Q1 | AGRTRDENG |
| LYONDELL CHEMICAL COMPANY | LYONDELL CHEMICAL COMPANY | $1.5M | Jul 21, 2025 | 2025Q2 | TAXTRAENV |
| INVESTMENT COMPANY INSTITUTE | INVESTMENT COMPANY INSTITUTE | $1.3M | Apr 18, 2025 | 2025Q1 | FINRETTAX |
| ASTRAZENECA PHARMACEUTICALS LP | ASTRAZENECA PHARMACEUTICALS LP | $1.2M | Apr 21, 2025 | 2025Q1 | HCRMMMPHA |
| CISCO SYSTEMS, INC | CISCO SYSTEMS INC | $840.0K | Apr 21, 2025 | 2025Q1 | BUDTAXCPT |
| BOSTON SCIENTIFIC CORPORATION | BOSTON SCIENTIFIC CORPORATION | $570.0K | Jul 17, 2025 | 2025Q2 | HCRVETTAX |
| DIAGEO NORTH AMERICA | DIAGEO NORTH AMERICA | $470.0K | Apr 21, 2025 | 2025Q1 | ALCTAXTRD |
| BOSTON SCIENTIFIC CORPORATION | BOSTON SCIENTIFIC CORPORATION | $400.0K | Apr 17, 2025 | 2025Q1 | HCRVETTAX |
| DIAGEO NORTH AMERICA | DIAGEO NORTH AMERICA | $370.0K | Jul 21, 2025 | 2025Q2 | ALCTAXTRD |
| RBC CAPITAL MARKETS, LLC | RBC CAPITAL MARKETS, LLC | $320.0K | Jul 18, 2025 | 2025Q2 | BANTAXFIN |
| CASE NEW HOLLAND INDUSTRIAL INC. | CASE NEW HOLLAND INDUSTRIAL INC | $310.0K | Apr 21, 2025 | 2025Q1 | CPTIMMAGR |
| CASE NEW HOLLAND INDUSTRIAL INC. | CASE NEW HOLLAND INDUSTRIAL INC | $300.0K | Jul 21, 2025 | 2025Q2 | TECFORLBR |
| SIX CONTINENTS HOTELS, INC. | SIX CONTINENTS HOTELS, INC. | $290.0K | Apr 21, 2025 | 2025Q1 | TOUTAXDEF |
| SYENSQO USA LLC | SYENSQO USA LLC | $220.0K | Jul 8, 2025 | 2025Q2 | AERAUTAVI |
| SYENSQO USA LLC | SYENSQO USA LLC | $220.0K | Apr 11, 2025 | 2025Q1 | AERAUTAVI |
| THE NICKLES GROUP, LLC | NOVO NORDISK, INC. | $80.0K | Jul 17, 2025 | 2025Q2 | HCRMMMTAX |
| THE NICKLES GROUP, LLC | NOVO NORDISK, INC. | $80.0K | Apr 17, 2025 | 2025Q1 | HCRMMMTAX |
| THE NICKLES GROUP, LLC | UCB, INC. | $60.0K | Apr 21, 2025 | 2025Q1 | MMMTAXHCR |
| OGR | GLOBAL BUSINESS ALLIANCE | $50.0K | Jul 19, 2025 | 2025Q2 | TAXFORECN |
| UNILEVER UNITED STATES, INC. | UNILEVER UNITED STATES, INC. | $50.0K | Jul 18, 2025 | 2025Q2 | ENVFOOCSP |
| THE NICKLES GROUP, LLC | CSL BEHRING LLC | $50.0K | Apr 21, 2025 | 2025Q1 | MMMHCRTAX |
| OGR | GLOBAL BUSINESS ALLIANCE | $50.0K | Apr 19, 2025 | 2025Q1 | TAXFORECN |
| UNILEVER UNITED STATES, INC. | UNILEVER UNITED STATES, INC. | $50.0K | Apr 17, 2025 | 2025Q1 | ENVFOOCSP |